Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 EUR | -1.80% | -0.61% | +1.23% |
Mar. 15 | Naturhouse Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Naturhouse Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 9.65 for the current year and 9.65 for next year, earnings multiples are highly attractive compared with competitors.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Ratings chart - Surperformance
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.23% | 105M | - | ||
+27.38% | 29.56B | A- | ||
+4.90% | 5.71B | B- | ||
-11.42% | 4.42B | C | ||
+14.25% | 4.17B | C+ | ||
+4.23% | 1.85B | - | B- | |
-4.59% | 1.77B | C+ | ||
-13.78% | 1.26B | - | C | |
-17.17% | 1.15B | B- | ||
-2.08% | 613M | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NTH Stock
- Ratings Naturhouse Health, S.A.